Loading viewer...
conference
Format: PDF conference
Hansa Biopharma presents its clinical-stage immunology pipeline and recently approved Idefirix for kidney transplantation in Europe. The company highlights its validated technology platform, expanded organization of 145 employees, and strong cash position through 2024, with applications across transplantation and autoimmune diseases.
investor_presentation
15 Pages
Hansa Biopharma Investor Presentation — April 2024
investor_presentationinvestor_presentation
99 Pages
conference
20 Pages
Roche
CapitaLand Investment Limited 2023 BofA ASEAN Conference
conferenceconference
56 Pages
CapitaLand Investment Limited
J.B. Hunt Transport Services 2022 Industrial Conference
conferenceconference
21 Pages
J.B. Hunt Transport Services, Inc.
Magellan Midstream Partners MLP Conference 2016
conferenceconference
20 Pages
Magellan Midstream Partners